Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Abnormal involuntary movement

Known as: Abnormal involuntary movements 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
Animal models of Parkinson's disease (PD) have proved highly effective in the discovery of novel treatments for motor symptoms of… Expand
  • table 1
  • figure 1
Is this relevant?
Highly Cited
2010
Highly Cited
2010
l-3,4-dihydroxyphenylalanine methyl ester hydrochloride (l-DOPA) is the gold standard for symptomatic treatment of Parkinson's… Expand
Is this relevant?
Highly Cited
2008
Highly Cited
2008
The development of abnormal involuntary movements (AIMs) or dyskinesias is a serious complication of l-DOPA [l-3,4… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 5
Is this relevant?
Highly Cited
2007
Highly Cited
2007
L-DOPA-induced dyskinesia (LID) is a major complication of the pharmacotherapy of Parkinson's Disease. A model of LID has… Expand
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Levodopa is the most commonly prescribed drug for Parkinson's disease (PD). Although levodopa improves PD symptoms in the initial… Expand
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Dopamine (DA) replacement therapy with l-DOPA remains the standard pharmacotherapy for Parkinson's disease (PD). Unfortunately… Expand
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Dyskinesia (abnormal involuntary movements) is a common complication of l-DOPA pharmacotherapy in Parkinson's disease, and is… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
Highly Cited
2002
Highly Cited
2002
In an attempt to define clinically relevant models of akinesia and dyskinesia in 6-hydroxydopamine (6-OHDA)-lesioned rats, we… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2002
Highly Cited
2002
In order to assess the role of striatal dopamine (DA) afferents in L-DOPA-induced dyskinesia, we have studied a large series of… Expand
Is this relevant?
Highly Cited
2000
Highly Cited
2000
We investigated the role of dopamine neurons in the manifestation of levodopa-induced dyskinesia in a rat model of Parkinson's… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?